Associated Papers
Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients.
Alnassar N et al.
Cancers, 2023
36900171 (PubMed )
Supplement: cancers-15-01378-s001.zip › cancers-2144737-supplementary_1_ › Supplementary_File_S2.xlsx › Low___High_DMD___Primary_Tumors
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › Patient_1_primary
Select a paper to view details